Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My take is they are saying if there are legal ramifications let HIKMA take them in exchange for the minimal initial market
Once its determined thaT they have no financial risk then they hop in
I posted this in the past but it makes more sense now with the patent issues - Instead of GBERT's combo pack make combo meds for the major statins
atorva-epa 10 20 or 40
rouso-epa 5 10 or 20
simva-epa 10 20 or 40
of course they have to be used for REDUCE IT - no way to generically substitute
My guess ...
Ashfield healthcare is managing european expansion
https://careers.ashfieldhealthcare.com/pt_PT/careers/JobDetail/General-Manager-Cardio/13382
my latest pharmacy notice ...
NOTICE *** Substitution of generic EPA for REDUCE IT indications is a violation of patent law and will be viewed as patent infringement. Parties that voluntarily engage or abet patent infringement will be held financially responsible.
Ashfield healthcare is managing european expansion
https://careers.ashfieldhealthcare.com/pt_PT/careers/JobDetail/General-Manager-Cardio/13382
Could be they dont want to risk damages if infringement goes against HIKMA - think about it why risk it - let HIKMA take risk if there is no infringement hop in then ....
Great idea !! Hilarious
Comes from me - I put it on their RX .....
Todays warning to Walmart on an RX :
Substitution for REDUCE IT indications are not allowed and will be viewed as patent infringement with resultant legal ramifications
When I screw up as a professional ...I get sued
ITs time for AMRN to stand up to NIssen - start attacking him as being petty and petulant for choosing to blindly accuse mineral oil as the culprit instead of his lack of ability to understand the basic biochemistry / cell physiology of DHA vs EPA
I wrote the White house about 6 mos ago ... no response ... try with the new administration but i strongly doubt they will be interested in supporting free Enterprise which 'increases' medication costs
Add one more ...failure to include a statin intolerant arm in REDUCE IT
The big stick has nothing to with science the big stick should be wielded to suppress patent infringement - right now all I see is a toothpick
The AMRN paradox ... true to its nature ... RX numbers reveal tremendous increase in generic % and stock price goes up .... too funny ....
AS I said several days ago - there is no sense in marketing if you have no market !!.. AMRN's first step in the US is legal - not medical - the infringement needs to cease - 800 reps are medical - put that money into legal and informing pharmacies of potential litigation a a result of their aiding and abetting the crime of patent infringement
I dont recall that NOrth
AMRN needs to highlight the disagreement - take Nissen's petty attempts and magnify them for everyone to see - you want press Dr. NIssen - sure we will give you all the press you want and show how you are either ignorant or vindictive - neither one is a good picture to be painted - have BHATT respond as if he is educating a three year old - that its really rather fundamental - its not the mineral oil its the DHA - this is not difficult to understand - the biochemistry is rather clear on the advantage of EPA over DHA and that is what REDUCE-IT was all about .... Bhatt should say that he is very sorry that the STRENGTH trial did not work - but its failure is proof that its EPA that works and that DHA is harmful . THat if Nissen would have studied the basic biochemistry of these substances that difference would have been obvious and STRENGTH failure would have been predicted .... Nissens petulance is simply a result of his realization of having failed to properly examine the basic biochemistry before proceeding with the study and now he tries to obfuscate for this shortcoming
Bhatt wipes the mat with NIssen like an experienced MMA fighter taking on the local golf pro .....
Peace on Earth and good will to all - when you encounter death of a loved one recall your words - one can be upset with Du's legal judgement yet still see her as a person - the first step to the atrocities of war is dehumanization .... Merry Christmas Irishpaddy
I am very sorry for her and any parent that has to watch or have their child die - it is truly one of the worse things that can happen in one's life .... it is disturbing to me that anyone on this board would celebrate such a thing ... along the same lines I came across an account I believe it was on twitter which was denigrating Judge DU to no end and I believe it was in someway signed AMRN investor - my guess is the account was placed by HIKMA hoping Judge DU or someone in her circle reads it then hold this against AMRN ....
... the "law" cannot permit patent infringement ... the substitution for REDUCE- IT indication is breaking the law ... and this is where AMRN should be focused - forget the 800 reps for now spend that money on 800 lawyers ...
Excellent summary TKE
This is clearly an issue that AMRN needs to address - their refusal , ineptness, lack of attention - whatever the reason is destroying their market. They hide behind their doors playing corporate chess while in the real world they are getting decimated
BB So AMRN gets damages ? When ?
SO let me get this straight - In the US where we have generics we have 800 reps and in Europe where there is no generic competition we have 5 ....
wow ...good find North !!
Great Idea - what better way to suggest that the CEO and BOD see hidden benefits not yet available to the public !!
Ranjo as per my post Post # 315083 - we need a CEO - we need a marketing team - that is getting this information out - that what will move stock price - transform understanding and you can move mountains - having the cure for cancer ...but not educating people on it - the stock will lay dormant ---
and this is AMRN lying dormant as a result of inability to motivate the masses by engendering scientific understanding and stimulating the press in this regard -
they need a marketing team - desperately - get rid of the 800 reps who arent doing a thing right now and start marketing to the media!!
5 more cents and we are at a 3 month high ... having bought at $4.xx IM still holding but not doing any more work for AMRN .... I write RX if it doesn't fill - give em whatever you want insurance company - the AMRN execs can give up some of their millions to fix that problem - not me
Short and distort requires a flurry of bad news - I am not seeing that ?
Retiredceo - Just wondering How does one throw money at to keep the stock price down ? Are you saying that someone is buying up every stock that is offered ? if that were the case then shouldn't price just start going up as the available supply at a certain level is exhausted?
Chartists
OK so I can understand why people react to chartists they way do - after all doesnt the reality of say a study that shows drug x works for disease y have a much more importance than some curve in a graph -- sure in my mind that is true however the flip side is this - stock price is all about emotion - what do people believe - is it possible by certain patterns in buying to predict how people are acting ? I do think this is possible - for example police and US security examines the amount of chatter going on etc to predict areas of violence or potential attacks -
I look at this as I do medical testing - its just another tool it can be right it can be wrong - given the choice though I would follow Buffets philosophy ( which is why I should not have bought AMRN ) find a company that is making money and buy it ....
The key to raising stock price - which Thero needs to address - is not the Covid study - the key is implanting into investor minds the idea that the drug reduces inflammation without immuno suppression - as exemplified by the covid study - we are not looking at selling the drug for covid ( although we may ) we are looking at a much vaster market in a myriad of disease processes - stock price booms -
Just more of the same - why are not the 800 reps educating pharmcists!! I give up - yup take your otc fish oil .... I'M selling out tired of wasting time on this company ....
"Patient needs refills on brovana, vascepa, and ipratropium bromide. insurance will not cover certain meds but substitutions can be made: duoneb for brovana, pharmacy recommended fish oil to replace vascepa. last visit 9/30. last cpe 9/16."
RFF is your RX for Trigs >500 or REDUCE-IT?
If the latter then can the state be sued for promoting patent infringement ?
I see the advantage of EPA is its an anti inflammatory that does not reduce the immune system
Yes that is the billion dollar question - if it worked on corona great - but then will it work in other respiratory viral illnesses ( ie the common cold ?) multibillion market !! very long shot but at this point we will grab any handhold given us - I think it probably wont work if it was amazing Bhatt would be totally quiet then hit the press with an explosive finding that would go totally viral ... we can dream
The modus operandi of insurance companies is to unnecessarily complicate the system for anyone trying to extra resources be it patient needing testing / meds or physician trying to get paid - the more you obfuscate ..the more cash you keep
NO one has questioned some have ignored ( mainly the large mail order ones)